Avallano

About Avallano

The startup develops an AI-enabled data privacy platform that enhances patient recruitment and retention for clinical trials by utilizing advanced algorithms to identify and engage suitable candidates. This technology addresses the challenge of inefficient participant outreach, enabling healthcare organizations to improve trial outcomes with a well-prepared pool of patients.

```xml <problem> Clinical trials face challenges in efficiently identifying, recruiting, and retaining suitable patient participants, leading to delays, increased costs, and potentially compromised trial outcomes. Traditional methods of patient outreach often prove ineffective, resulting in underprepared patient pools and hindering the progress of crucial research. </problem> <solution> Avallano offers an AI-powered clinical research platform designed to streamline patient engagement and accelerate clinical trial processes. The platform leverages generative AI to analyze and transform clinical trial protocols, forms, and processes, ensuring simplicity, accuracy, and consistency. By integrating disparate health records and normalizing patient data, Avallano enables the creation of comprehensive patient registries, facilitating the matching of patients to appropriate trials. The platform automates patient communication, delivers personalized educational materials, and provides real-time analytics on patient behavior, preferences, and demographics, enhancing patient retention and satisfaction. Avallano's solutions reduce paperwork, automate patient and clinical requirements, and eliminate duplication of effort, driving efficiency across participants and sites. </solution> <features> - Generative AI-powered insights on demand for actionable data analysis - Modular real-world data collection to capture diverse patient information - AI-driven communication modules for precise, real-time patient interaction - Patient-driven privacy controls to foster trust and transparency - Intuitive user design to minimize confusion and enhance user experience - Workflow automation to accelerate processes and reduce operational costs - Customizable modules and integration with existing clinical systems - Focused training resources to ensure smooth platform adoption - AI-powered matching of patients to clinical trials based on individual profiles - Mobile application for patient education, engagement, and retention </features> <target_audience> Avallano's primary customers include clinical research organizations (CROs), biopharmaceutical companies, and clinical trial sites seeking to optimize patient recruitment, engagement, and retention for clinical trials. </target_audience> ```

What does Avallano do?

The startup develops an AI-enabled data privacy platform that enhances patient recruitment and retention for clinical trials by utilizing advanced algorithms to identify and engage suitable candidates. This technology addresses the challenge of inefficient participant outreach, enabling healthcare organizations to improve trial outcomes with a well-prepared pool of patients.

Where is Avallano located?

Avallano is based in Greenville, United States.

When was Avallano founded?

Avallano was founded in 2019.

How much funding has Avallano raised?

Avallano has raised 4350000.

Location
Greenville, United States
Founded
2019
Funding
4350000
Employees
13 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

Avallano

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

The startup develops an AI-enabled data privacy platform that enhances patient recruitment and retention for clinical trials by utilizing advanced algorithms to identify and engage suitable candidates. This technology addresses the challenge of inefficient participant outreach, enabling healthcare organizations to improve trial outcomes with a well-prepared pool of patients.

avallano.com300+
Founded 2019Greenville, United States

Funding

$

Estimated Funding

$3M+

Team (10+)

No team information available.

Company Description

Problem

Clinical trials face challenges in efficiently identifying, recruiting, and retaining suitable patient participants, leading to delays, increased costs, and potentially compromised trial outcomes. Traditional methods of patient outreach often prove ineffective, resulting in underprepared patient pools and hindering the progress of crucial research.

Solution

Avallano offers an AI-powered clinical research platform designed to streamline patient engagement and accelerate clinical trial processes. The platform leverages generative AI to analyze and transform clinical trial protocols, forms, and processes, ensuring simplicity, accuracy, and consistency. By integrating disparate health records and normalizing patient data, Avallano enables the creation of comprehensive patient registries, facilitating the matching of patients to appropriate trials. The platform automates patient communication, delivers personalized educational materials, and provides real-time analytics on patient behavior, preferences, and demographics, enhancing patient retention and satisfaction. Avallano's solutions reduce paperwork, automate patient and clinical requirements, and eliminate duplication of effort, driving efficiency across participants and sites.

Features

Generative AI-powered insights on demand for actionable data analysis

Modular real-world data collection to capture diverse patient information

AI-driven communication modules for precise, real-time patient interaction

Patient-driven privacy controls to foster trust and transparency

Intuitive user design to minimize confusion and enhance user experience

Workflow automation to accelerate processes and reduce operational costs

Customizable modules and integration with existing clinical systems

Focused training resources to ensure smooth platform adoption

AI-powered matching of patients to clinical trials based on individual profiles

Mobile application for patient education, engagement, and retention

Target Audience

Avallano's primary customers include clinical research organizations (CROs), biopharmaceutical companies, and clinical trial sites seeking to optimize patient recruitment, engagement, and retention for clinical trials.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.